Allogenic platelet gel in the treatment of pressure sores: a pilot study.
Although platelet gel is considered one of the most popular tools in the treatment of chronic ulcers, current consensus on its use is not unanimous. A prospective randomised trial was carried out at the Plastic Surgery Unit of the 'Salvatore Maugeri' Foundation Hospital of Pavia (Italy). The study involved 13 patients affected by spinal cord injury with 16 pressure sores over a period of 20 months. The ulcer was considered the experimental unit of the study irrespective of the number of ulcers per patient. Each consecutive ulcer was randomised to be treated either with allogenic platelet gel or with current best practice approach to chronic wounds dressing protocol. At the end of the treatment 15 ulcers out of 16 improved clinically. No statistically significant difference was demonstrated in volume reduction between the two groups, although a statistically significant difference could be demonstrated in the onset time of granulation tissue proliferation as in the wounds treated with platelet gel the healing process was triggered earlier. Our study suggests that platelet gel is mostly effective within the first 2 weeks of treatment while a prolonged treatment does not provide any significant advantage versus the current best practice approach to chronic wounds protocols.
Scevola
Silvia
S
Department of Plastic and Reconstructive Surgery, University of Pavia -Salvatore Maugeri Foundation Research and Care Institute, Pavia, Italy. silvia.scevola@fsm.it
Nicoletti
Giovanni
G
Brenta
Federica
F
Isernia
Paola
P
Maestri
Marcello
M
Faga
Angela
A
D000279:Administration, Cutaneous; D000704:Analysis of Variance; D002908:Chronic Disease; D005260:Female; D005782:Gels; D006097:Granulation Tissue / Q000187:drug effects; D006801:Humans; D007558:Italy; D008297:Male; D010865:Pilot Projects; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology / Q000627:therapeutic use*; D003668:Pressure Ulcer / Q000145:classification / Q000209:etiology / Q000628:therapy*; D011446:Prospective Studies; D012720:Severity of Illness Index; D017592:Skin Care / Q000379:methods; D013119:Spinal Cord Injuries / Q000150:complications; D018709:Statistics, Nonparametric; D014184:Transplantation, Homologous / Q000379:methods; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects*
D005782:Gels; D010982:Platelet-Derived Growth Factor
Exp Cell Res. 1974 Aug;87(2):297-301
4370268
J Clin Invest. 1995 Sep;96(3):1336-50
7657809
Ann Intern Med. 2003 Oct 21;139(8):635-41
14568851
Surgery. 1990 Sep;108(3):508-12
2396195
Ann Surg. 1992 Oct;216(4):401-6; discussion 406-8
1417189
Plast Reconstr Surg. 2004 Nov;114(6):1502-8
15509939
Transfusion. 2004 Jul;44(7):1013-8
15225241
Transfus Apher Sci. 2004 Apr;30(2):145-51
15062754
Exp Cell Res. 2008 Jul 1;314(11-12):2176-86
18570917
Lancet. 1992 Jan 4;339(8784):23-5
1345953
Dermatol Nurs. 2007 Aug;19(4):343-9; quiz 350
17874603
Am J Surg. 2001 Jan;181(1):81-6
11248182
Cell Regul. 1990 Jul;1(8):555-66
1964089
Ann Surg. 1986 Sep;204(3):322-30
3753059
J Vasc Surg. 2003 Dec;38(6):1342-8
14681639
Stem Cells. 2007 Jul;25(7):1737-45
17395768
Arch Dermatol. 1989 Oct;125(10):1390-8
2679401
Am J Pathol. 1994 Dec;145(6):1399-410
7992843
Surg Gynecol Obstet. 1990 Jan;170(1):56-60
2403699
Arch Facial Plast Surg. 2007 May-Jun;9(3):174-83
17519207
Arch Surg. 1994 Feb;129(2):213-9
8304833
Blood. 1979 Apr;53(4):604-18
426909
Biomaterials. 2003 Aug;24(18):3095-100
12895582
Ann Surg. 2000 Apr;231(4):600-11
10749622
Clin Geriatr Med. 1997 Aug;13(3):565-73
9227945